Found 96 matching trials
Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine PHASE1 Background:
\- Malaria is a disease that is spread by mosquitoes. Research...
Show More Location
Malaria Research and Training Center
Learn More & Join Trial
Long-Term PF-06651600 for the Treatment of Alopecia Areata PHASE3 This is a global Phase 3 study to evaluate the safety and effectiveness of ...
Show More Location
The University of Alabama at Birmingham Hosptial Outreach Lab
Learn More & Join Trial
36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds N/A To further characterize the safety profile of Menactra vaccine and to ident...
Show More Location
Multiple Locations
Learn More & Join Trial
Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination PHASE2 The purpose of this trial is to describe antibody persistence and response ...
Show More Location
Multiple Locations
Learn More & Join Trial
Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation N/A The aim of this study is to generate local data on the safety of Menactra® ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old PHASE1 Phase I study to evaluate safety and immunogenicity in healthy adult subjec...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe PHASE3 Primary objective:
This study aimed to demonstrate the non-inferiority of ...
Show More Location
Investigational Site Number : 2031006
Learn More & Join Trial
Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects PHASE3 This study is designed to assess the safety and immunogenicity of a single ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age PHASE3 Primary Objective:
To demonstrate the non-inferiority of the antibody resp...
Show More Location
Investigational Site Number 3920001
Learn More & Join Trial
A Phase I, Randomized, Modified Single-blind, Active-controlled (Infants Only), Four-stage, Step-down, Comparative, Multi-center Study PHASE1 The study will include groups of adults, toddlers, and infants who will rec...
Show More Location
Multiple Locations
Learn More & Join Trial